Characterization of ACTN4 as a novel antiviral target against SARS-CoV-2
Characterization of ACTN4 as a novel antiviral target against SARS-CoV-2
About this item
Full title
Author / Creator
Zhu, Miao , Huang, Fang , Sun, Huize , Liu, Kunpeng , Chen, Zhen , Yu, Baocheng , Hao, Haojie , Liu, Haizhou , Ding, Shuang , Zhang, Xueyan , Liu, Lishi , Zhang, Kui , Ren, Jierao , Liu, Yi , Liu, Haibin , Shan, Chao and Guan, Wuxiang
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
The various mutations in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pose a substantial challenge in mitigating the viral infectivity. The identification of novel host factors influencing SARS-CoV-2 replication holds potential for discovering new targets for broad-spectrum antiviral drugs that can combat future viral mutations. In...
Alternative Titles
Full title
Characterization of ACTN4 as a novel antiviral target against SARS-CoV-2
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b62795e4eb444f78b95246bfce8025d2
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b62795e4eb444f78b95246bfce8025d2
Other Identifiers
ISSN
2059-3635,2095-9907
E-ISSN
2059-3635
DOI
10.1038/s41392-024-01956-4
